Skip to main content


AXS-05, an investigational modulated-delivery tablet combining dextromethorphan and bupropion, significantly improved symptoms of depression in patients with major depressive disorder (MDD) in a recent phase 3 trial, announced developer Axsome Therapeutics Inc.
Supplemental treatment with the medical food L-methylfolate may benefit patients with depression who do not respond to antidepressants, according to a review article published online in CNS Spectrums.
Although the prevalence of cannabis use in the United States grew among people with and without depression between 2005 and 2017, in 2017 cannabis use was twice as common among people with depression.
Having a parent with depression was associated with structural differences in the brains of 9- and 10-year-olds, according to a study published online in the Journal of the American Academy of Child & Adolescent Psychiatry.
Approximately 20% of people with major depressive disorder (MDD) experienced high or fluctuating suicidal ideation over 12 weeks of treatment with antidepressants, researchers found in a study published in The Journal of Clinical Psychiatry.
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Back to Top